Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2019 | 2 |
2020 | 1 |
2021 | 2 |
2022 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
A Single Domain Shark Antibody Targeting the Transferrin Receptor 1 Delivers a TrkB Agonist Antibody to the Brain and Provides Full Neuroprotection in a Mouse Model of Parkinson's Disease.
Pharmaceutics. 2022 Jun 24;14(7):1335. doi: 10.3390/pharmaceutics14071335.
Pharmaceutics. 2022.
PMID: 35890231
Free PMC article.
Animal models of Parkinson's disease: a guide to selecting the optimal model for your research.
Lama J, Buhidma Y, Fletcher EJR, Duty S.
Lama J, et al. Among authors: fletcher ejr.
Neuronal Signal. 2021 Dec 8;5(4):NS20210026. doi: 10.1042/NS20210026. eCollection 2021 Dec.
Neuronal Signal. 2021.
PMID: 34956652
Free PMC article.
Review.
Item in Clipboard
Drug repurposing strategies of relevance for Parkinson's disease.
Fletcher EJR, Kaminski T, Williams G, Duty S.
Fletcher EJR, et al.
Pharmacol Res Perspect. 2021 Aug;9(4):e00841. doi: 10.1002/prp2.841.
Pharmacol Res Perspect. 2021.
PMID: 34309236
Free PMC article.
Review.
Item in Clipboard
Neuroanatomical and Microglial Alterations in the Striatum of Levodopa-Treated, Dyskinetic Hemi-Parkinsonian Rats.
Fletcher EJR, Finlay CJ, Amor Lopez A, Crum WR, Vernon AC, Duty S.
Fletcher EJR, et al.
Front Neurosci. 2020 Sep 15;14:567222. doi: 10.3389/fnins.2020.567222. eCollection 2020.
Front Neurosci. 2020.
PMID: 33041762
Free PMC article.
Item in Clipboard
Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson's disease.
Fletcher EJR, Moon LDF, Duty S.
Fletcher EJR, et al.
BMC Neurosci. 2019 Dec 20;20(1):61. doi: 10.1186/s12868-019-0543-3.
BMC Neurosci. 2019.
PMID: 31862005
Free PMC article.
Item in Clipboard
Targeted repositioning identifies drugs that increase fibroblast growth factor 20 production and protect against 6-hydroxydopamine-induced nigral cell loss in rats.
Fletcher EJR, Jamieson AD, Williams G, Doherty P, Duty S.
Fletcher EJR, et al.
Sci Rep. 2019 Jun 6;9(1):8336. doi: 10.1038/s41598-019-44803-1.
Sci Rep. 2019.
PMID: 31171821
Free PMC article.
Item in Clipboard
Fibroblast growth factor 20 is protective towards dopaminergic neurons in vivo in a paracrine manner.
Boshoff EL, Fletcher EJR, Duty S.
Boshoff EL, et al. Among authors: fletcher ejr.
Neuropharmacology. 2018 Jul 15;137:156-163. doi: 10.1016/j.neuropharm.2018.04.017. Epub 2018 Apr 23.
Neuropharmacology. 2018.
PMID: 29698669
Free PMC article.
Item in Clipboard
Cite
Cite